Financials

SEC Filings

Filing date	Form	Description	View
Nov 3, 2021	CORRESP	CORRESP	0001193125-21-318381.pdf 0001193125-21-318381.rtf 0001193125-21-318381.xls View HTML
Apr 13, 2023	CORRESP	CORRESP	0001193125-23-100953.pdf 0001193125-23-100953.rtf 0001193125-23-100953.xls View HTML
Nov 17, 2023	CORRESP	CORRESP	0001193125-23-279802.pdf 0001193125-23-279802.rtf 0001193125-23-279802.xls View HTML
Apr 30, 2021	DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	0001193125-21-144962.pdf 0001193125-21-144962.rtf 0001193125-21-144962.xls View HTML
May 2, 2022	DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	0001193125-22-135208.pdf 0001193125-22-135208.rtf 0001193125-22-135208.xls View HTML
Apr 26, 2023	DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	0001819790-23-000014.pdf 0001819790-23-000014.rtf 0001819790-23-000014.xls View HTML
Apr 26, 2024	DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	0001819790-24-000056.pdf 0001819790-24-000056.rtf 0001819790-24-000056.xls View HTML
Apr 30, 2021	DEFA14A	Additional proxy soliciting materials - definitive	0001193125-21-144979.pdf 0001193125-21-144979.rtf 0001193125-21-144979.xls View HTML
May 2, 2022	DEFA14A	Additional proxy soliciting materials - definitive	0001193125-22-135228.pdf 0001193125-22-135228.rtf View HTML
Apr 26, 2023	DEFA14A	Additional proxy soliciting materials - definitive	0001819790-23-000015.pdf 0001819790-23-000015.rtf View HTML

Anchor Link for Quarterly Results

Data provided by Kaleidoscope.

© Tarsus Pharmaceuticals, Inc. All rights reserved. TARSUS, XDEMVY, and the associated logo are trademarks of Tarsus Pharmaceuticals, Inc.

From Fortune. ©2023 Fortune Media IP Limited. All rights reserved. Used under license. Fortune and Fortune Media IP Limited are not affiliated with, and do not endorse the products or services of, Tarsus.